Regenerative medicine strategies for treating neurogenic bladder

James J. Yoo, Jennifer Olson, Anthony Atala, Bupwan Kim

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Neurogenic bladder is a general term encompassing various neurologic dysfunctions of the bladder and the external urethral sphincter. These can be caused by damage or disease. Therapeutic management options can be conservative, minimally invasive, or surgical. The current standard for surgical management is bladder augmentation using intestinal segments. However, because intestinal tissue possesses different functional characteristics than bladder tissue, numerous complications can ensue, including excess mucus production, urinary stone formation, and malignancy. As a result, investigators have sought after alternative solutions. Tissue engineering is a scientific field that uses combinations of cells and biomaterials to encourage regeneration of new, healthy tissue and offers an alternative approach for the replacement of lost or deficient organs, including the bladder. Promising results using tissue-engineered bladder have already been obtained in children with neurogenic bladder caused by myelomeningocele. Human clinical trials, governed by the Food and Drug Administration, are ongoing in the United States in both children and adults to further evaluate the safety and efficacy of this technology. This review will introduce the principles of tissue engineering and discuss how it can be used to treat refractory cases of neurogenic bladder.

Original languageEnglish
Pages (from-to)109-119
Number of pages11
JournalInternational Neurourology Journal
Volume15
Issue number3
DOIs
StatePublished - Sep 1 2011
Externally publishedYes

Fingerprint

Neurogenic Urinary Bladder
Regenerative Medicine
Urinary Bladder
Tissue Engineering
Meningomyelocele
Urinary Calculi
Biocompatible Materials
Urethra
United States Food and Drug Administration
Mucus
Neurologic Manifestations
Regeneration
Research Personnel
Clinical Trials
Technology
Safety
Neoplasms

Keywords

  • Biomaterials
  • Reconstruction
  • Regenerative medicine
  • Tissue engineering
  • Urinary bladder

ASJC Scopus subject areas

  • Clinical Neurology
  • Urology
  • Neurology

Cite this

Regenerative medicine strategies for treating neurogenic bladder. / Yoo, James J.; Olson, Jennifer; Atala, Anthony; Kim, Bupwan.

In: International Neurourology Journal, Vol. 15, No. 3, 01.09.2011, p. 109-119.

Research output: Contribution to journalArticle

Yoo, James J. ; Olson, Jennifer ; Atala, Anthony ; Kim, Bupwan. / Regenerative medicine strategies for treating neurogenic bladder. In: International Neurourology Journal. 2011 ; Vol. 15, No. 3. pp. 109-119.
@article{54f77200446745f5ba2252ffb427d03d,
title = "Regenerative medicine strategies for treating neurogenic bladder",
abstract = "Neurogenic bladder is a general term encompassing various neurologic dysfunctions of the bladder and the external urethral sphincter. These can be caused by damage or disease. Therapeutic management options can be conservative, minimally invasive, or surgical. The current standard for surgical management is bladder augmentation using intestinal segments. However, because intestinal tissue possesses different functional characteristics than bladder tissue, numerous complications can ensue, including excess mucus production, urinary stone formation, and malignancy. As a result, investigators have sought after alternative solutions. Tissue engineering is a scientific field that uses combinations of cells and biomaterials to encourage regeneration of new, healthy tissue and offers an alternative approach for the replacement of lost or deficient organs, including the bladder. Promising results using tissue-engineered bladder have already been obtained in children with neurogenic bladder caused by myelomeningocele. Human clinical trials, governed by the Food and Drug Administration, are ongoing in the United States in both children and adults to further evaluate the safety and efficacy of this technology. This review will introduce the principles of tissue engineering and discuss how it can be used to treat refractory cases of neurogenic bladder.",
keywords = "Biomaterials, Reconstruction, Regenerative medicine, Tissue engineering, Urinary bladder",
author = "Yoo, {James J.} and Jennifer Olson and Anthony Atala and Bupwan Kim",
year = "2011",
month = "9",
day = "1",
doi = "10.5213/inj.2011.15.3.109",
language = "English",
volume = "15",
pages = "109--119",
journal = "International Neurourology Journal",
issn = "2093-4777",
publisher = "Korean Association of Medical Journal Edirors",
number = "3",

}

TY - JOUR

T1 - Regenerative medicine strategies for treating neurogenic bladder

AU - Yoo, James J.

AU - Olson, Jennifer

AU - Atala, Anthony

AU - Kim, Bupwan

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Neurogenic bladder is a general term encompassing various neurologic dysfunctions of the bladder and the external urethral sphincter. These can be caused by damage or disease. Therapeutic management options can be conservative, minimally invasive, or surgical. The current standard for surgical management is bladder augmentation using intestinal segments. However, because intestinal tissue possesses different functional characteristics than bladder tissue, numerous complications can ensue, including excess mucus production, urinary stone formation, and malignancy. As a result, investigators have sought after alternative solutions. Tissue engineering is a scientific field that uses combinations of cells and biomaterials to encourage regeneration of new, healthy tissue and offers an alternative approach for the replacement of lost or deficient organs, including the bladder. Promising results using tissue-engineered bladder have already been obtained in children with neurogenic bladder caused by myelomeningocele. Human clinical trials, governed by the Food and Drug Administration, are ongoing in the United States in both children and adults to further evaluate the safety and efficacy of this technology. This review will introduce the principles of tissue engineering and discuss how it can be used to treat refractory cases of neurogenic bladder.

AB - Neurogenic bladder is a general term encompassing various neurologic dysfunctions of the bladder and the external urethral sphincter. These can be caused by damage or disease. Therapeutic management options can be conservative, minimally invasive, or surgical. The current standard for surgical management is bladder augmentation using intestinal segments. However, because intestinal tissue possesses different functional characteristics than bladder tissue, numerous complications can ensue, including excess mucus production, urinary stone formation, and malignancy. As a result, investigators have sought after alternative solutions. Tissue engineering is a scientific field that uses combinations of cells and biomaterials to encourage regeneration of new, healthy tissue and offers an alternative approach for the replacement of lost or deficient organs, including the bladder. Promising results using tissue-engineered bladder have already been obtained in children with neurogenic bladder caused by myelomeningocele. Human clinical trials, governed by the Food and Drug Administration, are ongoing in the United States in both children and adults to further evaluate the safety and efficacy of this technology. This review will introduce the principles of tissue engineering and discuss how it can be used to treat refractory cases of neurogenic bladder.

KW - Biomaterials

KW - Reconstruction

KW - Regenerative medicine

KW - Tissue engineering

KW - Urinary bladder

UR - http://www.scopus.com/inward/record.url?scp=84859627669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859627669&partnerID=8YFLogxK

U2 - 10.5213/inj.2011.15.3.109

DO - 10.5213/inj.2011.15.3.109

M3 - Article

C2 - 22087419

AN - SCOPUS:84859627669

VL - 15

SP - 109

EP - 119

JO - International Neurourology Journal

JF - International Neurourology Journal

SN - 2093-4777

IS - 3

ER -